M

Mustang Bio
D

MBIO

0.23520
USD
-0.01
(-4.85%)
Market Closed
Volume
4,963
EPS
0
Div Yield
0
P/E
-0
Market Cap
8,757,112
OverviewSignalsIdeasNews
Related Instruments
    A
    ARCT
    -1.880
    (-8.01%)
    21.600 USD
    B
    BNGO
    -0.05270
    (-8.23%)
    0.58760 USD
    L
    LPTX
    -0.02000
    (-0.93%)
    2.12000 USD
    O
    OSUR
    0.01000
    (0.22%)
    4.50000 USD
    V
    VBIV
    -0.00920
    (-7.34%)
    0.11610 USD
    V
    VERU
    -0.04740
    (-5.06%)
    0.88900 USD
    V
    VYNE
    -0.06400
    (-3.42%)
    1.81000 USD
    More
News

Title: Mustang Bio

Sector: Healthcare
Industry: Biotechnology
Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipelineis currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.